X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
female (6) 6
humans (6) 6
oncology (6) 6
aged (5) 5
male (5) 5
middle aged (5) 5
mutation (5) 5
adult (4) 4
indoles - therapeutic use (4) 4
melanoma - drug therapy (4) 4
sulfonamides - therapeutic use (4) 4
aged, 80 and over (3) 3
pathway (3) 3
protein kinase inhibitors - therapeutic use (3) 3
proto-oncogene proteins b-raf - antagonists & inhibitors (3) 3
skin neoplasms - drug therapy (3) 3
skin neoplasms - pathology (3) 3
activation (2) 2
adolescent (2) 2
animals (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
article (2) 2
braf (2) 2
dabrafenib (2) 2
disease-free survival (2) 2
drug resistance, neoplasm (2) 2
immunohistochemistry (2) 2
indoles - administration & dosage (2) 2
indoles - adverse effects (2) 2
map kinase signaling system - drug effects (2) 2
mek (2) 2
melanoma (2) 2
mice (2) 2
mitogen-activated protein kinase kinases - metabolism (2) 2
patients (2) 2
plx4032 (2) 2
proliferation (2) 2
proto-oncogene proteins - metabolism (2) 2
proto-oncogene proteins b-raf - genetics (2) 2
proto-oncogene proteins p21 (2) 2
ras mutations (2) 2
ras proteins - metabolism (2) 2
sulfonamides - administration & dosage (2) 2
sulfonamides - adverse effects (2) 2
survival (2) 2
therapy (2) 2
tumors (2) 2
vemurafenib (2) 2
abl expression levels (1) 1
abridged index medicus (1) 1
acquired-resistance (1) 1
activating mutations (1) 1
administration, oral (1) 1
amplification (1) 1
antineoplastic agents - therapeutic use (1) 1
apoptosis - drug effects (1) 1
biomarkers, tumor - genetics (1) 1
biomarkers, tumor - metabolism (1) 1
braf gene (1) 1
carcinogenesis (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
carcinoma, squamous cell - drug therapy (1) 1
carcinoma, squamous cell - genetics (1) 1
cell cycle - drug effects (1) 1
cell line, tumor (1) 1
cell lines (1) 1
cell proliferation - drug effects (1) 1
cells (1) 1
chronic lymphocytic-leukemia (1) 1
clinical trials as topic (1) 1
cuscc (1) 1
dacarbazine (1) 1
dacarbazine - therapeutic use (1) 1
dehydrogenases (1) 1
dermatologic (1) 1
diagnosis (1) 1
disease progression (1) 1
dna, neoplasm - analysis (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
end-point (1) 1
erlotinib hydrochloride (1) 1
extracellular signal-regulated kinase (1) 1
feasibility studies (1) 1
follow-up studies (1) 1
gefitinib (1) 1
gene copy number (1) 1
gene expression (1) 1
gene expression regulation, neoplastic (1) 1
genes, ras (1) 1
group-study br.21 (1) 1
gtp phosphohydrolases - genetics (1) 1
guidelines (1) 1
hematology (1) 1
hematology, oncology and palliative medicine (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 11/2011, Volume 29, Issue 31, pp. 4113 - 4120
Purpose The phase III, randomized, placebo-controlled Sequential Tarceva in Unresectable NSCLC (SATURN; BO18192) study found that erlotinib maintenance therapy... 
TRIAL | K-RAS MUTATIONS | GEFITINIB | RECEPTOR INTRON-1 POLYMORPHISM | ONCOLOGY | IN-SITU HYBRIDIZATION | GROUP-STUDY BR.21 | PHASE-II | GENE COPY NUMBER | METASTATIC COLORECTAL-CANCER | ACTIVATING MUTATIONS | Erlotinib Hydrochloride | Immunohistochemistry | Lung Neoplasms - drug therapy | Predictive Value of Tests | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Prospective Studies | Humans | Lung Neoplasms - metabolism | Middle Aged | ras Proteins - metabolism | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Feasibility Studies | Receptor, Epidermal Growth Factor - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Quinazolines - administration & dosage | DNA, Neoplasm - analysis | Odds Ratio | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Drug Administration Schedule | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Proto-Oncogene Proteins - genetics | Sequence Analysis, DNA | Polymorphism, Genetic | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 3, pp. 207 - 215
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2013, Volume 31, Issue 14, pp. 1767 - 1774
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 12006 - 12006
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 655 - 655
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 08/2019
GREEN (NCT01905943) is a nonrandomized, open-label, single-arm, phase 3b study investigating the safety and efficacy of obinutuzumab alone or in combination... 
Journal Article
Cancer Research, ISSN 0008-5472, 02/2012, Volume 72, Issue 4, pp. 969 - 978
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 1820 - 1820
Abstract Introduction Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma and has an aggressive natural history. Rituximab (R), a... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 2514 - 2514
Abstract Abstract 2514 Chronic lymphocytic leukemia (CLL), the most frequent leukemia in adults, still remains poorly understood. Several prognostic markers... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.